The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on ...

Measles, one of the world’s most contagious diseases, was declared eliminated in the US in 2000, due to widespread use of the measles-mumps-rubella vaccine.

Increased risk seen in adjusted analyses in association with nucleoside and nucleotide reverse transcriptase inhibitor use.

Recommendations focus on radiation therapy and/or adjunctive therapies for WHO grade 4 adult-type diffuse glioma.

Exposure-response association seen between trihalomethanes and CKD risk; highest risk seen for brominated trihalomethanes.

The REMS program for the ERA drug class was established due to the risk of embryofetal toxicity seen from animal studies.

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

After 8 months of taking the wrong medication, Miss G developed a rash. Her mother took her to the emergency department (ED) ...

HealthDay News — Patients undergoing retinal detachment (RD) repair with concomitant cannabis use have a lower risk for subsequent proliferative vitreoretinopathy (PVR) and requiring subsequent ...

An analysis of pharmacokinetic data showed ET-600 was bioequivalent to an FDA-approved oral desmopressin product.

The lawsuit was prompted by several recent HHS actions the plaintiffs noted were “designed to mislead, confuse, and gradually desensitize the public to anti-vaccine and anti-science rhetoric.” ...

The FDA considers the recall “terminated,” meaning it’s no longer active. But officials are urging parents to check their shelves just in case.